AGGRENOX has an established safety profile

The general safety and tolerability of AGGRENOX was demonstrated in the largest stroke prevention trial ever: the Second European Stroke Prevention Study (ESPS 2). And AGGRENOX has been taken safely by hundreds of thousands of patients in the United States and around the world.

The most common side effect is headache (38.2% vs 32.4% with placebo), which usually diminishes over time.

Most people starting with AGGRENOX do not get a headache and for many, the headache is mild. Your body will adjust naturally and the headaches should go away in a matter of days. Headaches associated with AGGRENOX usually go away within a week of starting to take it.

Other side effects include GI bleeding which, was comparable to aspirin (4.1% vs 3.2%).

If you are concerned about headache or other symptoms, don’t stop taking AGGRENOX, but contact your doctor. He or she may be able to help you better deal with these symptoms while your body adjusts to the medicine.

WHAT’S RELATED?

You may also be interested in reading:

AGGRENOX Effectiveness
How to Take AGGRENOX

Get FREE resources on TIA and stroke. Click here

If you can’t afford your AGGRENOX, our patient assistance program may be able to help.
Call 1 800 556 8317.

Important Information about AGGRENOX

AGGRENOX is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis.

In clinical trials, the most common adverse event with AGGRENOX was headache (38.2% vs 32.4% with placebo), which was more frequent at the onset of therapy but diminished over time. GI bleeding with AGGRENOX was comparable to aspirin (4.1% vs 3.2%) and intracranial hemorrhage with AGGRENOX was similar to placebo (0.6% vs 0.4%).

AGGRENOX contains aspirin. Patients who consume three or more alcoholic drinks every day should be counseled about the bleeding risks involved with chronic, heavy alcohol use while taking aspirin. Even low doses of aspirin can increase bleeding time, which can adversely affect patients with bleeding disorders. Patients with a history of active peptic ulcer disease should avoid using aspirin, which can cause gastric mucosal irritation and bleeding. AGGRENOX should be avoided in the third trimester of pregnancy.

Click here for full AGGRENOX Prescribing Information.